Recursion Pharmaceuticals (RXRX) Q2 2023 Earnings

8AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.38
-0.35
-0.32
-0.29

Details

Expected EPS
-0.37
Actual EPS
-0.38
Surprise EPS
-0.01
Surprise Percent
+2.7%

Description

Recursion Pharmaceuticals (RXRX) has reported earnings of -0.38 per share for Q2 2023.

0 Comments

Share your thoughts